Suppr超能文献

相似文献

1
Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway.
Am J Transl Res. 2025 Apr 15;17(4):2396-2410. doi: 10.62347/MOBZ7773. eCollection 2025.
2
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
Neuropharmacology. 2020 Nov 1;178:108225. doi: 10.1016/j.neuropharm.2020.108225. Epub 2020 Aug 3.
3
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD009329. doi: 10.1002/14651858.CD009329.pub2.
4
Antidepressants for smoking cessation.
Cochrane Database Syst Rev. 2023 May 24;5(5):CD000031. doi: 10.1002/14651858.CD000031.pub6.
5
The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Psychopharmacology (Berl). 2018 Sep;235(9):2479-2505. doi: 10.1007/s00213-018-4921-9. Epub 2018 Jul 7.
6
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.
Cochrane Database Syst Rev. 2023 Sep 12;9(9):CD015226. doi: 10.1002/14651858.CD015226.pub2.
7
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.
8
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.
9
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2011 Feb 16(2):CD006103. doi: 10.1002/14651858.CD006103.pub5.
10
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev. 2010 Dec 8(12):CD006103. doi: 10.1002/14651858.CD006103.pub4.

本文引用的文献

1
Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines' immunogenicity.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2140552. doi: 10.1080/21645515.2022.2140552. Epub 2022 Nov 9.
3
Cannabinoid receptor GPR55 activation blocks nicotine use disorder by regulation of AMPAR phosphorylation.
Psychopharmacology (Berl). 2021 Nov;238(11):3335-3346. doi: 10.1007/s00213-021-05949-x. Epub 2021 Oct 14.
5
Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators.
Neuropharmacology. 2020 May 15;168:108008. doi: 10.1016/j.neuropharm.2020.108008. Epub 2020 Feb 12.
7
Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.
J Am Coll Cardiol. 2018 Aug 28;72(9):1030-1045. doi: 10.1016/j.jacc.2018.06.036.
9
Effects of concurrent blockade of OX2 and CB1 receptors in the ventral tegmental area on nicotine-induced place preference in rats.
Neurosci Lett. 2018 Sep 25;684:121-126. doi: 10.1016/j.neulet.2018.07.017. Epub 2018 Jul 12.
10
The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Psychopharmacology (Berl). 2018 Sep;235(9):2479-2505. doi: 10.1007/s00213-018-4921-9. Epub 2018 Jul 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验